Puoti M, Foster GR, Wang S. et al. High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis. J Hepatol 2018; 69: 293-300
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.